Osteopoikilosis and ankylosing spondylitis: a rare coexistence and good response to TNF blocker adalimumab

Publisher： John Wiley & Sons Inc

E-ISSN： 1756-185x|18|3|372-374

ISSN： 1756-1841

Source： INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol.18, Iss.3, 2015-03, pp. : 372-374

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased levels of soluble TNF-like cytokine 1A in ankylosing spondylitis

By Konsta Maria  

British Journal of Rheumatology , Vol. 52, Iss. 3, 2013-03 ,pp. : 448-451

Oxford University Press

Access to resources Recommend Favorite

Ankylosing spondylitis

By Wolf Jeanette  

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 9-10, 2010-05 ,pp. : 211-214

Springer Publishing Company

Access to resources Recommend Favorite

Observational study of switching anti-TNF agents in ankylosing spondylitis and psoriatic arthritis versus rheumatoid arthritis

By Haberhauer Guenther  

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 9-10, 2010-05 ,pp. : 220-224

Springer Publishing Company

Access to resources Recommend Favorite

The paradoxical effects of TNF inhibitors on bone mineral density and radiographic progression in patients with ankylosing spondylitis

By Kang Kwi Young  

British Journal of Rheumatology , Vol. 52, Iss. 4, 2013-04 ,pp. : 718-726

Oxford University Press

Access to resources Recommend Favorite

Infliximab: a chimeric anti-TNF-αα monoclonal antibody for the treatment of ankylosing spondylitis and other spondyloarthritides

By Baeten Dominique  

Therapy, Vol. 3, Iss. 2, 2006-03 ,pp. : 191-200

Future Medicine

Access to resources Recommend Favorite